GGrantIndex
Sort

64,565 grants matching drug discovery

DCTD Functional Genomics

$1,133,280
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA

DNA Topoisomerases as Target of Action of Anticancer Drugs

$1,132,850
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Development of an Integrated Platform for the Use of Adult Human Primary Cardiomyocytes in Preclinical Safety Assessment

$1,132,289
Najah Abi Gerges · Anabios Corporation · R44 · FY2020 · TR

Preclinical drug development in pancreatic cancer

$1,131,974
Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Multi-Center Study of Pancreatic Cancer Etiology

$1,131,891
John D Potter · Kaiser Foundation Health Plan Of Washington · R01 · FY2007 · CA

Response Therapies for MDR-TB

$1,131,873
Ian M Orme · Colorado State University · U01 · FY2008 · AI

Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance

$1,131,504
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2020 · CA

MPS Qualification Section

$1,131,489
Mark E Schurdak · University Of Pittsburgh At Pittsburgh · U2C · FY2025 · TR

Nephrotic Syndrome Rare Disease Clinical Research Network

$1,131,277
Matthias Kretzler · University Of Michigan At Ann Arbor · U54 · FY2017 · DK

Center for Biomolecular NMR Data Processing and Analysis

$1,130,894
Jeffrey C Hoch · University Of Connecticut Sch Of Med/Dnt · P41 · FY2017 · GM

Effect of Tumors on the Skeleton

$1,130,748
Gregory R Mundy · Vanderbilt University · P01 · FY2006 · CA

Effect of Tumors on the Skeleton

$1,130,480
Gregory R Mundy · Vanderbilt University · P01 · FY2007 · CA

Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD

$1,130,445
Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · R01 · FY2021 · AG

Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD

$1,130,445
Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · R01 · FY2019 · AG

Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD

$1,130,445
Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · R01 · FY2022 · AG

Harnessing Molecular Networks of Resilience for Therapeutic Discoveries in AD

$1,130,444
Nilufer Ertekin-Taner · Mayo Clinic Jacksonville · R01 · FY2020 · AG

Discovery And Functional Genomics Of Environmental Response Genes

$1,130,282
Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2017 · ES

CNTR OF EXCELLENCE FOR PROSTATE CANCER RESEARCH EDUCATION AND COMM SERVICE

$1,130,266
Shafiq A Khan · Clark Atlanta University · P20 · FY2016 · MD

Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines

$1,130,011
Christopher A. Gaiteri · Upstate Medical University · R01 · FY2023 · AG

Tissue Chip Modeling of Synovial Joint Pathologies: Effects of Inflammation and Adipose-Mediated Diabetic Complications

$1,129,655
Rocky S. Tuan · University Of Pittsburgh At Pittsburgh · UG3 · FY2017 · TR

Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy

$1,129,408
Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA

Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance

$1,129,373
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2021 · CA

Assay Development and High Throughput Screening Core

$1,129,304
Zhong-Yin Zhang · Indiana University Indianapolis · U54 · FY2019 · AG

The Role of B cells in the Origin and Progression of Multiple Sclerosis

$1,129,237
Stephen L Hauser · University Of California, San Francisco · R35 · FY2023 · NS

The Role of B cells in the Origin and Progression of Multiple Sclerosis

$1,129,237
Stephen L Hauser · University Of California, San Francisco · R35 · FY2022 · NS